# Lenalidomide After Allo Transplant

> **NCT01750762** · PHASE1 · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Multiple Myeloma
- Lymphoma

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01750762
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01750762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01750762, "Lenalidomide After Allo Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01750762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*